Ji Li

Ji Li is an accomplished professional with a diverse background in business development, finance, and operations.

Education wise, Ji Li holds a Ph.D. from Columbia University in the City of New York and a B.S. from Peking University, showcasing a strong academic foundation.

Currently, Ji Li serves as the Head of Business Development, Finance & Operations at Immune-Onc Therapeutics, displaying expertise and leadership in the biotechnology industry.

In the past, Ji Li has held various key roles at Immune-Onc Therapeutics, including Chief Of Staff, Sr. Director of Alliance Management & Business Operations, and Director of Alliance Management & Business Operations, illustrating a progressive career trajectory within the organization.

Prior to joining Immune-Onc Therapeutics, Ji Li accumulated experience as the Director of Marketing Strategy & Operations at Natera and as a FAST Program Advisor at the California Life Sciences Association (CLSA).

Ji Li also has consulting experience, having worked as an Associate Director and Managing Consultant at Navigant, where valuable skills in strategic planning and project management were honed.

Additionally, Ji Li has been involved in various leadership and liaison roles, such as being a Program Leader and Greater China Liaison at the Startup Leadership Program, showcasing a commitment to fostering professional networks and growth.

Moreover, Ji Li has a solid research background, having served as a Graduate Student Researcher at Columbia University and as a Technology Licensing Intern at Columbia Technology Ventures, highlighting a blend of academic and practical knowledge.

Ji Li's diverse experiences, combined with a strong educational foundation and an ability to excel in leadership and strategic roles, make them a valuable asset in the biotechnology and consulting sectors.